相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Blood biomarkers with Parkinson's disease clusters and prognosis: the oxford discovery cohort
Michael Lawton et al.
MOVEMENT DISORDERS (2020)
Transcriptomic signatures of brain regional vulnerability to Parkinson's disease
Arlin Keo et al.
COMMUNICATIONS BIOLOGY (2020)
Prioritizing Parkinson's disease genes using population-scale transcriptomic data
Yang Li et al.
NATURE COMMUNICATIONS (2019)
Data-Driven Subtyping of Parkinson's Disease Using Longitudinal Clinical Records: A Cohort Study
Xi Zhang et al.
SCIENTIFIC REPORTS (2019)
Alteration of Tremor Dominant and Postural Instability Gait Difficulty Subtypes During the Progression of Parkinson's Disease: Analysis of the PPMI Cohort
Jeong Won Lee et al.
FRONTIERS IN NEUROLOGY (2019)
Recent advances and perspectives of metabolomics-based investigations in Parkinson's disease
Yaping Shao et al.
MOLECULAR NEURODEGENERATION (2019)
Electroencephalography-based machine learning for cognitive profiling in Parkinson's disease: Preliminary results
Nacim Betrouni et al.
MOVEMENT DISORDERS (2019)
Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease
Eduardo De Pablo-Fernandez et al.
JAMA NEUROLOGY (2019)
Subtyping of Parkinson's Disease - Where Are We Up To?
Elizabeth Qian et al.
AGING AND DISEASE (2019)
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
Cynthia Rudin
NATURE MACHINE INTELLIGENCE (2019)
The importance of an independent validation cohort for metabolomics biomarker studies
Jean-Pierre Trezzi et al.
MOVEMENT DISORDERS (2018)
Developing and validating Parkinson's disease subtypes and their motor and cognitive progression
Michael Lawton et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Personalized Medicine in Parkinson's Disease: Time to Be Precise
Nataliya Titova et al.
MOVEMENT DISORDERS (2017)
Selective neuronal vulnerability in Parkinson disease
D. James Surmeier et al.
NATURE REVIEWS NEUROSCIENCE (2017)
Biological and Clinical Implications of Comorbidities in Parkinson's Disease
Jose A. Santiago et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression
Seyed-Mohammad Fereshtehnejad et al.
BRAIN (2017)
Anxiety and anxious-depression in Parkinson's disease over a 4-year period: a latent transition analysis
S. Landau et al.
PSYCHOLOGICAL MEDICINE (2016)
CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study
Ju-Hee Kang et al.
ACTA NEUROPATHOLOGICA (2016)
Distribution and Load of Amyloid-β Pathology in Parkinson Disease and Dementia with Lewy Bodies
Dagmar H. Hepp et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2016)
How stable are Parkinson's disease subtypes in de novo patients: Analysis of the PPMI cohort?
Tanya Simuni et al.
PARKINSONISM & RELATED DISORDERS (2016)
Nonmotor Predictors for Levodopa Requirement in De Novo Patients With Parkinson's Disease
Roberto Erro et al.
MOVEMENT DISORDERS (2015)
Integrating Pathways of Parkinson's Disease in a Molecular Interaction Map
Kazuhiro A. Fujita et al.
MOLECULAR NEUROBIOLOGY (2014)
A clinico-pathological study of subtypes in Parkinson's disease
M. Selikhova et al.
BRAIN (2009)
Course in Parkinson disease subtypes A 39-year clinicopathologic study
A. H. Rajput et al.
NEUROLOGY (2009)
There is no Parkinson disease
William J. Weiner
ARCHIVES OF NEUROLOGY (2008)
Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease
Joerg Spiegel et al.
MOVEMENT DISORDERS (2007)
Functional decline in Parkinson disease
J Jankovic et al.
ARCHIVES OF NEUROLOGY (2001)
Parkinson's disease subtypes: clinical classification and ventricular cerebrospinal fluid analysis
MC Schiess et al.
PARKINSONISM & RELATED DISORDERS (2000)
分享论文
